Healthcare -
Biotechnology - NASDAQ - US
$ 61.53
0.457 %
$ 11.7 B
Market Cap
37.07
P/E
BMRN - SHORT-TERM DEBT
Short-term Debt BMRN - BioMarin Pharmaceutical Inc.
503 M
LAST VALUE
593.09%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR